Behavioral Activation for Serious Mental Illness

N/A

Recruiting

Research Sponsored by Temple University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up administered 3 times for 2 weeks: at baseline, within 1 month following the 10 weeks of weekly meetings, and 3 months later within 1 month following the end of the intervention

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to test a new program to help people with serious mental illness become more active and involved in their communities. Participants will attend weekly online sessions for 10 weeks and then monthly sessions for

Who is the study for?

This trial is for individuals with serious mental illnesses like Schizoaffective Disorder, Schizophrenia, various forms of Depression, Bipolar Disorder, Psychosis, and Mood Disorders. Participants should be willing to engage in online sessions and use a GPS app to track movement.

What is being tested?

The study tests Behavioral Activation intervention aimed at increasing activity variety and community participation among the mentally ill. It involves weekly online sessions for 10 weeks followed by monthly check-ins over three months.

What are the potential side effects?

Since this is a behavioral intervention rather than a medication or medical procedure, traditional side effects are not expected. However, participants may experience changes in mood or stress due to new activities or increased social interactions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ administered 3 times for 2 weeks: at baseline, within 1 month following the 10 weeks of weekly meetings, and 3 months later within 1 month following the end of the intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~administered 3 times for 2 weeks: at baseline, within 1 month following the 10 weeks of weekly meetings, and 3 months later within 1 month following the end of the intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and administered 3 times for 2 weeks: at baseline, within 1 month following the 10 weeks of weekly meetings, and 3 months later within 1 month following the end of the intervention for reporting.